Clinical Trial Update: Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating immunotherapy after organ transplantation to prevent skin cancer in transplant recipients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Cutaneous Squamous Cell Carcinoma
• Skin Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Immunotherapy, Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: WITHDRAWN